Kaplan–Meier curve analyses revealed that both overall survival and biochemical recurrence-free survival of PCa patients with high Rab25 expression were significantly shorter than those with low Rab25 expression (both P < 0.001, Fig. 3). The gene discussed is RAB25; the disease is posterior cortical atrophy.